Korro Bio (KRRO) Institutional Ownership → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free KRRO Stock Alerts $50.24 -0.76 (-1.49%) (As of 04:27 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Korro Bio (NASDAQ:KRRO)CurrentInstitutional OwnershipPercentage13.18%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$97.50MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$387.63K Get KRRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Korro Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KRRO Institutional Buying and Selling by Quarter Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Korro Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Vanguard Group Inc.266,667$24M0.0%-1.6%3.324% 2/20/2024Eventide Asset Management LLC546,325$26.19M0.4%N/A73.828% 2/14/202472 Investment Holdings LLC276,831$13.27M58.9%N/A37.410% 2/12/2024Monashee Investment Management LLC90,805$4.35M0.8%N/A12.271% 2/9/2024 Atlas Venture Life Science Advisors LLC1,119,292$53.65M6.4%N/A151.256% 1/10/2024 North Star Investment Management Corp.1,000$48K0.0%N/A0.135% (Data available from 1/1/2016 forward) KRRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KRRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Korro Bio shares: Atlas Venture Life Science Advisors LLC ($53.65M), Eventide Asset Management LLC ($26.19M), Vanguard Group Inc. ($24M), 72 Investment Holdings LLC ($13.27M), and Monashee Investment Management LLC ($4.35M), North Star Investment Management Corp. ($48K).Learn more on KRRO's institutional investors. What percentage of Korro Bio stock is owned by institutional investors? 13.18% of Korro Bio stock is owned by institutional investors. Learn more on KRRO's institutional investor holdings. Which institutional investors have been buying Korro Bio stock? The following institutional investors have purchased Korro Bio stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($1.12M), Eventide Asset Management LLC ($546.33K), 72 Investment Holdings LLC ($276.83K), Monashee Investment Management LLC ($90.81K), and North Star Investment Management Corp. ($1K). How much institutional buying is happening at Korro Bio? Institutional investors have bought a total of 2,034,253 shares in the last 24 months. This purchase volume represents approximately $97.50M in transactions. Which Korro Bio major shareholders have been selling company stock? The following institutional investors have sold Korro Bio stock in the last 24 months: Vanguard Group Inc. ($4.31K). How much institutional selling is happening at Korro Bio? Institutional investors have sold a total of 4,307 shares in the last 24 months. This volume of shares sold represents approximately $387.63K in transactions. Related Companies: Heron Therapeutics Major Shareholders Biomea Fusion Major Shareholders Annexon Major Shareholders Lexicon Pharmaceuticals Major Shareholders Neurogene Major Shareholders Mersana Therapeutics Major Shareholders Corbus Pharmaceuticals Major Shareholders Esperion Therapeutics Major Shareholders PepGen Major Shareholders Revance Therapeutics Major Shareholders This page (NASDAQ:KRRO) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.